DNA methylation inhibitors in cancer: recent and future approaches

Area of Science:

• Biochemistry
• Molecular Biology
• Oncology

Background:

• DNA methyltransferases (DNMTs) are crucial enzymes involved in epigenetic regulation.
• Aberrant DNA methylation is a hallmark of various cancers.
• Understanding DNMTs is key to developing targeted cancer therapies.

Purpose of the Study:

• To review human DNA methyltransferases (DNMTs), their functions, and their involvement in cancer.
• To describe assays for identifying DNMT inhibitors (DNMTi).
• To summarize current DNMTi, their clinical applications, and future prospects.

Main Methods:

• Literature review of DNMTs, their roles in cancer, and DNMT inhibitors.
• Analysis of existing assays for DNMT inhibitor screening.
• Compilation of data on DNMTi clinical trials and their outcomes.

Main Results:

• Detailed overview of human DNMTs, including their biological functions and mechanisms.
• Description of various assays used to detect DNMT inhibitors.
• Summary of known DNMT inhibitors, highlighting their pros, cons, and clinical trial status.

Conclusions:

• DNMTs play a significant role in cancer development and progression.
• DNMT inhibitors represent a promising therapeutic strategy for cancer treatment.
• Further research into novel DNMT inhibitors is warranted for improved cancer therapies.